PART I Overview Imagine a world where diseases like cancer and sepsis can be diagnosed early and monitored easily using routine blood tests. Thats the world Volition is trying to build by developing its innovative family of simple, easy to use, cost-effective blood tests. Volition is a multi-national epigenetics company. It has patented technologies that use chromosomal structures, such as nucleosomes, and transcription factors as biomarkers in cancer and other diseases. The tests in the Company...
Q2 FY2026 — expected 2026-08-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001477932-26-001832 | EDGAR | 67K words |
| 2025-03-31 | 2024-12-31 | 0001477932-25-002231 | EDGAR | — |
| 2024-03-25 | 2023-12-31 | 0001477932-24-001453 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001477932-23-001497 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001477932-22-001740 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001078782-21-000262 | EDGAR | — |
| 2020-02-20 | 2019-12-31 | 0001078782-20-000134 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001078782-19-000220 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001078782-18-000250 | EDGAR | — |
| 2017-03-10 | 2016-12-31 | 0001078782-17-000302 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001477932-25-008186 | EDGAR | 33K words |
| 2025-08-14 | 2025-06-30 | 0001477932-25-005923 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001477932-25-003853 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001477932-24-007207 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001477932-24-004842 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001477932-24-002775 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001477932-23-008451 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001477932-23-006106 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001477932-23-003240 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001477932-22-008533 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001477932-22-005796 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001477932-22-003197 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001477932-26-001940 | EDGAR | 1K words |
| 2026-03-31 | 0001477932-26-001830 | EDGAR | — |
| 2026-02-20 | 0001477932-26-000955 | EDGAR | — |
| 2026-02-09 | 0001477932-26-000714 | EDGAR | — |
| 2026-01-08 | 0001477932-26-000107 | EDGAR | — |
| 2025-12-11 | 0001477932-25-008932 | EDGAR | — |
| 2025-11-13 | 0001477932-25-008182 | EDGAR | — |
| 2025-11-07 | 0001477932-25-007984 | EDGAR | — |
| 2025-10-14 | 0001477932-25-007544 | EDGAR | — |
| 2025-08-14 | 0001477932-25-005919 | EDGAR | — |
242 total filings indexed. 210 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000093314 |
| Ticker | VNRX |
| Exchange | NYSE |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Website | https://www.volition.com |
| Listed | 2007-04-25 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report